European Archives - Page 976 of 1516 - European Medical Journal

EMJ Podcast: Advancements in the Treatment of Moderate-to-Severe Atopic Dermatitis

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the final instalment in a five-part series exploring the subject of atopic dermatitis (AD).

EMJ Podcast: The Metropolis of Marginalisation

This week, Jonathan sits down with three leaders from the charity accelerator The Voluntary Solidarity Fund (VSF) to discuss the topic of marginalisation.

EMJ Podcast: Unmet Needs Among Patients with Atherosclerotic Cardiovascular Disease Receiving Statin

This episode, sponsored by an educational grant from Amarin Corporation, is a discussion around primary prevention and treatment of atherosclerotic cardiovascular disease (ASCVD).

Talking to Rodrigo Garcia

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

What Factors Affect Timing of Menopause?

Combining multiple health surveys in a meta-analysis, Duke Appiah, Texas Tech University, Lubbock, Texas, USA, has produced interesting insights for the duration of a woman’s reproductive span. Lifestyle factors were analysed to show associations with the date women reach natural menopause.

Women with PCOS at High Risk for COVID-19

Domminating the statistics for infertility in women, polycystic ovary syndrome (PCOS) is the most common cause of this condition, with onset as a result of imbalanced reproductive hormones. Emerging evidence suggests a co-interaction of PCOS with infectious disease.

EMJ Podcast: COVID to Ground Control

This week, Jonathan muses on the importance of emerging from the pandemic safely, addressing conspiracy theories, vaccine hesitancy, public uncertainty, and the role of strong leadership, all through an analogy of aviation.

Prostate specific antigen PSA blood culture sample with catheter and collection tubes.

Webinar: Beyond PSA: Utility of a Urine Gene Expression Assay for Early Detection of Prostate Cancer

PSA remains the gold standard as a first-line screening test, but is limited in terms of specificity, especially among older men. We now have available new, non-invasive biomarkers which can help men decide whether to proceed with biopsy, in order to find high-grade, potentially lethal tumors early while minimizing over-diagnosis of low-grade, indolent tumors.

The expectation vs reality of drug launch

This infographic reviews drug launches from recent years, comparing the expectation vs reality of launch, the increase in first-time launchers, and the impact of COVID-19 on the landscape.

Editor's Pick: Relating Ventilatory Support and Drug Treatment Strategies to the Fundamental Pathophysiology in COVID-19 Illness

Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);1 as of September 2020, there were >33 million…